|
Variables
|
Active disease (n = 11)
|
Remission (n = 18)
|
p
|
|---|
|
HMGB1, ng/ml
|
1.31 (0.63–2.16)
|
0.75 (0.39–2.05)
|
0.281
|
|
ESR, mm/1st hour
|
39.0 (25.0–68.0)
|
17.5 (8.0–25.5)
|
0.017
|
|
CRP, mg/l
|
6.0 (4.4–24.9)
|
2.0 (0.1–10.7)
|
0.053
|
|
ITAS2010
|
3.0 (2.2–5.2)
|
--
|
--
|
|
ITAS.A ESR
|
3.5 (2.0–6.2)
|
1.0 (1.0–1.7)
|
0.001
|
|
ITAS.A CRP
|
5.1 ± 2.5
|
2.1 ± 0.9
|
0.012
|
|
Statins, n (%)
|
7 (63.6)
|
9 (50.0)
|
0.702
|
|
Prednisone, n (%)
|
6 (54.5)
|
10 (55.6)
|
0.958
|
|
Prednisone daily dose, mg
|
20.0 (7.5–45.0)
|
5.0 (2.5–13.7)
|
0.055
|
|
Immunosuppressive agents, n (%)
|
7 (63.6)
|
12 (66.7)
|
0.868
|
|
Biological agents, n (%)
|
3 (27.3)
|
6 (33.3)
|
0.732
|
- Continuous variables are presented as median and interquartile range or as mean ± standard deviation
-
CRP C-reactive protein, ESR erythrocyte sedimentation rate, ITAS Indian Takayasu activity score, ITAS.A Indian Takayasu activity score with acute phase response, HMGB1 high mobility group box 1, n number of patients
